Authors: Martha Powell, Future Science Group
Today at our booth
The morning kicked off looking at a year in infection control and excellent talks followed including tuberculosis and vaccine development. At our booth we had some lovely delegates, who had signed up last year, drop by with some great feedback and also Expert Panelist Glenn Tillotson paid us a visit, a reminder that if you haven’t already signed up, you should!
Remember to find us at booth #150, or follow out Twitter updates @IDHubFSG.
Video highlights
Picture of the Day
The flags in the main reception area welcome delegates from all over the world
More of today’s news
Best of social media #ECCMID2018
Blanket use of #corticosteroids in #CAP is not beneficial. We need to define which group, if any, may have benefit (patient, #pathogen, severity) and which steroid (and dose, route) is best. Precision is key! #ECCMID2018 #ICU @ESCMID pic.twitter.com/UwfKj6zBnK
— David Griffin (@drdavidwjg) April 23, 2018
Poster session at #ECCMID2018 @ESCMID is buzzing 😃 👍 pic.twitter.com/H2qkv4BLKv
— Hanna Sidjabat (@DrHannaSidjabat) April 23, 2018
Just finished late breaker infection control abstract session at #ECCMID2018. Take home point only one study was classic infection control (contact precautions). All others were prophylaxis or decontamination with antibiotics. Infection control science is stagnant.
— Eli Perencevich 😷 (@eliowa) April 23, 2018
#ECCMID2018 George Daikos @uoaofficial: there is no evidence-based support for most combination therapies against carbapenem-resistant Gram-negative bacteria#youareonyourown#AntimicrobialStewardship
— Alicia D (@aliciad3) April 23, 2018
Didn’t read yesterday’s update? You can still catch up with all the news here.
